The evolution of medulloblastoma therapy to personalized medicine [version 1; referees: 3 approved]
Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signal...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2017-04-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/6-490/v1 |